Clin2
NCT06756841Worth exploringNot yet recruiting

Electric pulse therapy for advanced esophageal cancer

Esophageal Cancer

Part of Cancer, Digestive system clinical trials.

This trial tests a new treatment that uses short electric pulses (pulsed electric field) to target and damage cancer cells in the esophagus. It is for people with advanced esophageal cancer that cannot be removed by surgery, and it aims to be safe and potentially shrink or slow the tumor.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10 people
Ages
20 years and older
Study type
Interventional

Who can take part

  • You are at least 20 years old.
  • You are physically able to care for yourself (daily activity score 0 or 1), with no severe limitation.
  • Your blood counts and liver function are within certain safe limits (like adequate infection-fighting cells and platelets).
  • You have no active infection that needs antibiotics or antiviral medicine.
  • Your cancer cannot be removed by surgery or cured with radiation plus chemotherapy.
  • You have not had a stent placed in your esophagus or airway, and do not have a pacemaker or similar electronic device.
  • You have not had a major gastrointestinal bleed in the last month, and no high risk of bleeding from the tumor.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06787313Recruiting
Precision palliative care for advanced esophageal cancer

This trial studies a personalized approach to palliative care for people with advanced or recurrent esophageal cancer who are being treated with immunotherapy. It aims to improve quality of life and symptom management.

Shanghai, Shanghai Municipality
NCT06906887Recruiting· Phase 2
Pulsed low-dose radiation vs standard chemoradiation for esophageal cancer

This trial compares a new way of giving radiation (in short, pulsed low-dose bursts) to the standard method, both combined with chemotherapy, for people with esophageal cancer. It aims to see if the pulsed approach is safer and equally effective.

Milwaukee, Wisconsin
NCT06739031Recruiting
Testing pulsed electric field ablation for small lung tumors

This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.

Shanghai
NCT06122493Recruiting· Phase 2
Better treatment for advanced esophageal cancer

This trial tests a new treatment plan for people with advanced esophageal squamous cell carcinoma that has spread to lymph nodes but not to other organs. It aims to find the best way to treat this cancer using radiation and other therapies.

Shanghai, Shanghai Municipality
NCT07487844Recruiting
Electric field therapy for breast cancer that has spread

This trial tests a new way to treat breast cancer that has spread to the skin or just under the skin. It uses short electric pulses to target tumors without cutting. The goal is to see if this approach can safely destroy cancer cells in those spots.

San Francisco, California
NCT07799194Not yet recruiting
Electric pulse treatment for early-stage lung cancer

This study tests a new treatment that uses electric pulses to destroy early-stage lung tumors without surgery. It is for people who cannot have surgery or radiation, or who choose not to.

Guangzhou, Guangdong

Hear when a new Esophageal Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.